Markets › India › BOM › MERCURYLAB

Mercury Laboratories Limited

BOM:MERCURYLABHealthcare

₹745.65−1.24%At closeAt close · Tue 20 Oct · ≈ AED 28.81 · Market cap $9.53M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	33.3%	59.2%	59.6%	59.6%	61.5%	33.7%	—	—
Operating margin	12.1%	8.4%	8.3%	10.1%	39.1%	7.4%	7.4%	+0.0 pts
Net margin	7.8%	6.1%	7.4%	7.5%	4.2%	6.4%	6.4%	+0.0 pts
EBITDA margin	15.3%	13.7%	13.7%	13.4%	10.8%	14.0%	—	—
Return on equity	14.5%	8.8%	12.2%	11.1%	5.9%	8.3%	8.3%	+0.0 pts
Return on assets	8.2%	5.6%	8.3%	8.3%	4.2%	6.1%	6.1%	+0.0 pts
Return on capital employed	17.8%	10.2%	12.2%	13.9%	49.6%	8.3%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	10.9%	9.5%	8.6%	8.2%	7.3%	10.7%	—	—
Interest coverage	12.9×	10.9×	17.3×	20.0×	53.6×	10.3×	—	—
Current ratio	2.0×	2.2×	2.4×	3.1×	2.7×	3.8×	3.8×	+0.0%
Quick ratio	1.7×	1.8×	2.0×	2.6×	2.2×	3.2×	—	—
Cash ratio	0.2×	0.3×	0.2×	0.3×	0.0×	0.5×	0.5×	+0.0%
Asset turnover	1.0×	0.9×	1.1×	1.1×	1.0×	1.0×	—	—
Inventory turnover	8.9×	3.5×	4.4×	4.9×	4.0×	7.1×	—	—
Receivables turnover	3.0×	3.5×	3.5×	3.4×	2.9×	2.9×	—	—
Dividend payout	7.9%	6.7%	7.5%	7.4%	13.4%	8.7%	—	—